7521 - 7530 of 7861 Results
Title
Year
- β2-Adrenergic Receptor Activation Prevents Rodent Dopaminergic Neurotoxicity by Inhibiting Microglia via a Novel Signaling Pathway2011RESTRICTEDTitle: β2-Adrenergic Receptor Activation Prevents Rodent Dopaminergic Neurotoxicity by Inhibiting Microglia via a Novel Signaling PathwayJournal Name: The Journal of ImmunologyPublisher: The American Association of ImmunologistsVol: 186Issue #: 7Start Page: 4443End Page: 4454Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.4049/jimmunol.1002449Best OA location URL: https://journals.aai.org/jimmunol/article-pdf/186/7/4443/1340946/1002449.pdfCitation Count: 108
-
RESTRICTEDTitle: In vivo demonstration that α-synuclein oligomers are toxicJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 108Issue #: 10Start Page: 4194End Page: 4199Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1073/pnas.1100976108Best OA location URL: https://europepmc.org/articles/pmc3053976?pdf=renderCitation Count: 1332
-
RESTRICTEDTitle: MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophyJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 7Start Page: 670End Page: 672Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31820c30c1Best OA location URL: https://europepmc.org/articles/pmc3053340?pdf=renderCitation Count: 70
-
RESTRICTEDTitle: Substantia nigra hyperechogenicity with LRRK2 G2019S mutationsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 5Start Page: 885End Page: 888Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23644Best OA location URL: https://europepmc.org/articles/pmc3082617?pdf=renderCitation Count: 34
- Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease2011RESTRICTEDTitle: Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 42Issue #: 3Start Page: 327End Page: 340Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2011.01.024Best OA location URL: https://lup.lub.lu.se/search/files/1732507/1885514.pdfCitation Count: 160
- Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-Aβ deposits in hippocampus via distinct cellular mechanisms2011RESTRICTEDTitle: Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-Aβ deposits in hippocampus via distinct cellular mechanismsJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 121Issue #: 6Start Page: 705End Page: 719Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s00401-011-0806-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-011-0806-2.pdfCitation Count: 54
-
RESTRICTEDTitle: Mitochondrial DNA haplogroups and mutations in children with acquired central demyelinationJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 9Start Page: 774End Page: 780Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31820ee1bbBest OA location URL: https://europepmc.org/articles/pmc3053335?pdf=renderCitation Count: 17
- Evaluation of the D3 dopamine receptor selective agonist/partial agonist PG01042 on l-dopa dependent animal involuntary movements in rats2011RESTRICTEDTitle: Evaluation of the D3 dopamine receptor selective agonist/partial agonist PG01042 on l-dopa dependent animal involuntary movements in ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 60Issue #: 2-3Start Page: 284End Page: 294Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2010.09.011Best OA location URL: https://europepmc.org/articles/pmc3820002?pdf=renderCitation Count: 20
-
RESTRICTEDTitle: Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson’s diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 18Issue #: 5Start Page: 756End Page: 765Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1468-1331.2011.03353.xBest OA location URL: https://europepmc.org/articles/pmc3556904?pdf=renderCitation Count: 106
-
RESTRICTEDTitle: Essential tremor and Parkinson's disease: Lack of a linkJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 3Start Page: 372End Page: 377Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23509Best OA location URL: https://europepmc.org/articles/pmc3070808?pdf=renderCitation Count: 59